Brief: Gen Ilac Says It Signs Supply And Distribution Agreement With Incyte On Oct 9
12/10/2026 09:11
BRIEF-Gen Ilac Says It Signs Supply And Distribution Agreement With Incyte On Oct 9 Oct 12 (Reuters) - Gen Ilac ve Saglik Urunleri Sanayi Ticaret A.S. GENIL.IS:
GEN ILAC - SIGNS SUPPLY AND DISTRIBUTION AGREEMENT WITH INCYTE ON OCT 9
GEN ILAC - GRANTED EXCLUSIVE RIGHTS FOR REGISTRATION, SALES, MARKETING, AND DISTRIBUTION
GEN ILAC - RECEIVES EXCLUSIVE RIGHTS FOR NIKTIMVO (AXATILIMAB) IN TURKEY
GEN ILAC - RECEIVES EXCLUSIVE RIGHTS FOR OPZELURA (RUXOLITINIB) IN TURKEY AND AZERBAIJAN
GEN ILAC - AGREEMENT TERM IS 5 YEARS FROM FIRST COMMERCIAL SALE
Source text: nIKAkLFtG
Further company coverage: GENIL.IS
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com;; +48 58 7696600;))
Recent news on Gen Ilac ve Saglik Urunleri Sanayi Ticaret
See all newsBrief: Gen Ilac Says It Wins Pharmaceutical Tender In Kazakhstan, Expects $1.19 Million Sales Contribution In 2027
Brief: Gen Ilac Says It Participates In Kazakhstan Drug Procurement Tender Via Med Service Plus Authorized By Kazakhstan Representative Office Of Gen Ilac
Brief: Gen Ilac Says It Signs Supply And Distribution Agreement With Incyte On Oct 9
Brief: Gen Ilac Says It Completes Pharmaceutical Manufacturing Plant Investment In Azerbaijan
Brief: Gen Ilac Says It Is To Start Share Buyback Programme For Max 125 Mln Nominal Shares With Allocated Funds Of 1.5 Bln Lira